---
schema_version: "secwatch.filing_event.v1"
accession: "0001683168-25-005180"
form_type: "8-K"
ticker: "RDNT"
cik: "0000790526"
company_name: "RadNet, Inc."
filed_at: "2025-07-17T23:59:59+00:00"
generated_at: "2026-05-18T06:06:03.021585+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# RadNet completes iCAD acquisition via DeepHealth subsidiary; expands AI breast health

## Summary
- DeepHealth, RadNet's digital health segment, closed acquisition of iCAD (NASDAQ: ICAD).
- iCAD's AI portfolio includes breast cancer detection, risk evaluation, and density assessment in 50+ countries.
- Combined installed base of 1,500+ healthcare provider locations, covering over 10 million mammograms annually.
- Acquisition positions DeepHealth with industry-leading AI-powered breast cancer screening and workflow solutions.
- iCAD will operate as a wholly-owned subsidiary of RadNet, integrated into DeepHealth.

## SEC filing metadata
- accession: 0001683168-25-005180
- form_type: 8-K
- ticker: RDNT
- cik: 0000790526
- company_name: RadNet, Inc.
- filed_at: 2025-07-17T23:59:59+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/790526/000168316825005180/0001683168-25-005180-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/790526/000168316825005180/radnet_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001683168-25-005180
- JSON: https://secwatch.observer/filing/0001683168-25-005180.json
- Plain text: https://secwatch.observer/filing/0001683168-25-005180.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.